Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Organogenesis (ORGO) vs Siga Technologies Inc. (SIGA)

Organogenesis and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $233.5M against $207.1M — 1.1× the size. Organogenesis grew revenue faster over the last twelve months: 6.50% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −22.2%) and the higher return on invested capital (−14.6% vs −20.0%). Across the 19 metrics below, Organogenesis leads on 11 and Siga Technologies Inc. on 8.

Valuation

Metric ORGO SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 0.39 4.61 2.25
P/B 1.22 1.50 1.90
Price to free cash flow 8.64 n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.33 2.45 2.56
Earnings yield (60.71%) (1.16%) (2.99%)
Free cash flow yield 11.57% (8.29%) 0.00%

Profitability

Metric ORGO SIGA Drug Manufacturers Specialty & Generic median
Gross margin 70.35% 54.35% 53.94%
Operating margin (7.84%) (20.76%) 0.00%
Net margin (22.23%) (5.19%) 0.00%
Free cash flow margin 4.56% (37.58%) 0.00%
Return on equity (53.31%) (1.49%) (0.40%)
Return on assets (23.44%) (1.36%) (3.32%)
Return on invested capital (19.97%) (14.59%) 0.00%

Growth

Metric ORGO SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 6.50% (70.13%) 10.01%
EPS growth (last fiscal year) 1,600.00% (60.98%) —
Revenue growth, 5-year CAGR 10.77% (5.42%) 6.74%
Net income growth, 5-year CAGR 3.04% (16.20%) 0.00%

Health

Metric ORGO SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.07 0.00 0.05
Current ratio 3.52 21.72 2.31
Net debt to EBITDA (1.14) (6.39) 0.85

Dividend

Metric ORGO SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ORGO SIGA Drug Manufacturers Specialty & Generic median
Market cap 207.13m 233.51m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack